Our mission is to create a new society in which people will not lose their lives by using urine tests to provide "early, painless and accurate early diagnosis of cancer" It is known that detecting cancer early increases the survival rate 5 to 10 times and greatly improves the prognosis.
However, it is not unusual for many cancers to have no subjective symptoms, and when they become aware they have progressed to a stage where treatment is impossible. The most effective way to detect cancer at an early stage that can be treated is to have regular and high-precision cancer diagnosis, but existing cancer diagnosis is painful and However, many of them are not accurate enough and are not suitable for regular diagnosis and early stage diagnosis.
Total Funding: N/A
Funding Stage: Series A
Business Stage: Scaling Up
Market: B2B
Company Size: 1 to 25
Founded: 2018
Bioinformatics / Machine Learning Engineer
Tokyo, Tokyo
Clinical Laboratory Technician
Nagoya, Nagoya
Experimental Assistant (Life Science)
Nagoya, Nagoya
Researcher (Chemistry / Microfabrication / Semiconductor)
Nagoya, Nagoya
Researcher (Life Science)
Nagoya, Nagoya
